SCHEMBL5687828

SCHEMBL5687828

O=C(O)Cc1ccc(OCC2CCN(C(=O)Oc3ccc(CCSc4ccncc4)cc3)CC2)cc1

nearest known ligand 0.40

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
GRIN2B Q13224 3/20 0.39
MGLL Q99685 1/20 0.39
SLC2A1 P11166 1/20 0.39
LIPE Q05469 1/20 0.39
CYP2C9 P11712 3/20 0.38
CYP2D6 P10635 1/20 0.38
TBXAS1 P24557 1/20 0.37
FFAR1 O14842 1/20 0.37
CYP4F2 P78329 2/20 0.37
CYP4A11 Q02928 2/20 0.37
CYP1A2 P05177 2/20 0.37
CYP3A4 P08684 2/20 0.37
ALDH1A1 P00352 2/20 0.36
KDM4E B2RXH2 1/20 0.36
NPY2R P49146 1/20 0.36
USP2 O75604 1/20 0.36
CYP2C19 P33261 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5688472 0.91 SLC2A1 (0.42) GRIN2BMGLLSLC2A1LIPECYP2C9
SCHEMBL5687670 0.89 TBXAS1 (0.42) GRIN2BMGLLSLC2A1LIPECYP2C9
SCHEMBL5688131 0.87 EPHX2 (0.45) CYP2C9CYP2D6CYP1A2CYP3A4ALDH1A1
SCHEMBL5690231 0.87 HSD11B1 (0.44) GRIN2BMGLLSLC2A1LIPECYP4F2
SCHEMBL5687223 0.86 GRIN2B (0.42) GRIN2BMGLLLIPECYP4F2CYP4A11
SCHEMBL5688300 0.85 LIPE (0.47) GRIN2BMGLLSLC2A1LIPECYP2C9
SCHEMBL5931704 0.84 GRIN2B (0.37) GRIN2BMGLLLIPETBXAS1CYP4F2
SCHEMBL5931577 0.83 LIPE (0.47) GRIN2BSLC2A1LIPECYP4F2CYP4A11
SCHEMBL5690010 0.81 CYP2C9 (0.37) GRIN2BMGLLSLC2A1LIPECYP2C9
SCHEMBL5691280 0.81 ALDH1A1 (0.36) GRIN2BMGLLSLC2A1LIPECYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060160851-A1 Substituted piperidine carbamates NOVO NORDISK A/S (DK) 2006-07-20 US claimed
CN-1805951-A Substituted piperidine carbamates for use as inhibitors of hormone sensitive lipase NOVO NORDISK AS (DK) 2006-07-19 CN claimed
EP-1636207-A1 SUBSTITUTED PIPERIDINE CARBAMATES FOR USE AS INHIBITORS OF HORMONE SENSITIVE LIPASE NOVO NORDISK A/S (DK) 2006-03-22 EP claimed
WO-2004111032-A1 SUBSTITUTED PIPERIDINE CARBAMATES FOR USE AS INHIBITORS OF HORMONE SENSITIVE LIPASE NOVO NORDISK A/S (DK) 2004-12-23 WO claimed
US-20060160851-A1 Substituted piperidine carbamates NOVO NORDISK A/S (DK) 2006-07-20 US disclosed
CN-1805951-A Substituted piperidine carbamates for use as inhibitors of hormone sensitive lipase NOVO NORDISK AS (DK) 2006-07-19 CN disclosed
EP-1636207-A1 SUBSTITUTED PIPERIDINE CARBAMATES FOR USE AS INHIBITORS OF HORMONE SENSITIVE LIPASE NOVO NORDISK A/S (DK) 2006-03-22 EP disclosed
WO-2004111032-A1 SUBSTITUTED PIPERIDINE CARBAMATES FOR USE AS INHIBITORS OF HORMONE SENSITIVE LIPASE NOVO NORDISK A/S (DK) 2004-12-23 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060160851-A1 Substituted piperidine carbamates LIPE, PNLIP, LIPC GRIN2B 2588/4885MGLL 39/4885SLC2A1 2134/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.